A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer

Daniela Fenoglio, Paolo Traverso, Alessia Parodi, Laura Tomasello, Simone Negrini, Francesca Kalli, Florinda Battaglia, Francesca Ferrera, Stefania Sciallero, Giuseppe Murdaca, Maurizio Setti, Alberto Sobrero, Francesco Boccardo, Giuseppe Cittadini, Francesco Puppo, Domenico Criscuolo, Giorgio Carmignani, Francesco Indiveri, Gilberto Filaci

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'A multi-peptide, dual-adjuvant telomerase vaccine (GX301) is highly immunogenic in patients with prostate and renal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences